NASDAQ:DRIODarioHealth Stock Price, Forecast & News

DarioHealth's stock was trading at $6.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, DRIO shares have decreased by 8.6% and is now trading at $6.30. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DarioHealth in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for DarioHealth.

DarioHealth is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for DarioHealth.

DarioHealth Corp (NASDAQ:DRIO) issued its quarterly earnings results on Tuesday, May, 12th. The company reported ($1.57) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.75) by $0.82. The company earned $1.67 million during the quarter. DarioHealth had a negative net margin of 318.61% and a negative return on equity of 200.83%. View DarioHealth's earnings history.

2 brokers have issued twelve-month target prices for DarioHealth's shares. Their forecasts range from $8.00 to $10.00. On average, they expect DarioHealth's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price. View analysts' price targets for DarioHealth.

News articles about DRIO stock have been trending negative on Monday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. DarioHealth earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about DarioHealth.

DarioHealth saw a increase in short interest in June. As of June 30th, there was short interest totaling 19,200 shares, an increase of 481.8% from the June 15th total of 3,300 shares. Based on an average trading volume of 68,200 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.7% of the company's stock are sold short. View DarioHealth's Current Options Chain.

Some companies that are related to DarioHealth include SANUWAVE Health (SNWV), Nephros (NEPH), AIT Therapeutics (AITB), Pro-Dex (PDEX), BRAINSWAY LTD/S (BWAY), Nephros (NEPHD), Titan Medical (TMDI), Sensus Healthcare (SRTS), Motus GI (MOTS), STRATA Skin Sciences (SSKN), Apollo Endosurgery (APEN), Neuronetics (STIM), Atossa Genetics (ATOS), Arch Therapeutics (ARTH) and Delcath Systems (DCTH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other DarioHealth investors own include AEterna Zentaris (AEZS), Vascular Biogenics (VBLT), NANO DIMENSION/S (NNDM), Pluristem Therapeutics (PSTI), CorMedix (CRMD), AbbVie (ABBV), Dropcar (DCAR), Evoke Pharma (EVOK), Gilead Sciences (GILD) and Inovio Pharmaceuticals (INO).

DarioHealth trades on the NASDAQ under the ticker symbol "DRIO."

Shares of DRIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DRIO stock can currently be purchased for approximately $6.30.

DarioHealth has a market capitalization of $23.88 million and generates $7.56 million in revenue each year. DarioHealth employs 69 workers across the globe.

The official website for DarioHealth is www.mydario.com.

DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The company can be reached via phone at 972-4770-4055 or via email at [email protected]